Mattias Belting

Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial

Ehinger, Erik; Darabi, Anna; Visse, Edward; Edvardsson, Charlotte et al.

Ingår i Trials, 2025

• DOI för Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial
• Ladda ner fulltext (pdf) av Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial

Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

Wicher, Grzegorz; Roy, Ananya; Vaccaro, Alessandra; Vemuri, Kalyani et al.

Ingår i Neuro-Oncology Advances, 2025

• DOI för Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
• Ladda ner fulltext (pdf) av Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

Godina, Christopher; Khazaei, Somayeh; Belting, Mattias; Vallon-Christersson, Johan et al.

Ingår i PLOS ONE, 2024

• DOI för High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
• Ladda ner fulltext (pdf) av High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

Godina, Christopher; Belting, Mattias; Vallon-Christersson, Johan; Isaksson, Karolin et al.

Ingår i Scientific Reports, 2024

• DOI för Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
• Ladda ner fulltext (pdf) av Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer

Godina, Christopher; Tryggvadottir, Helga; Bosch, Ana; Borgquist, Signe et al.

Ingår i Breast Cancer Research and Treatment, s. 335-347, 2023

• DOI för Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
• Ladda ner fulltext (pdf) av Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer

Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial

Ehinger, Erik; Darabi, Anna; Visse, Edward; Edvardsson, Charlotte et al.

Ingår i Trials, 2025

• DOI för Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial
• Ladda ner fulltext (pdf) av Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial

Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

Wicher, Grzegorz; Roy, Ananya; Vaccaro, Alessandra; Vemuri, Kalyani et al.

Ingår i Neuro-Oncology Advances, 2025

• DOI för Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
• Ladda ner fulltext (pdf) av Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression

High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

Godina, Christopher; Khazaei, Somayeh; Belting, Mattias; Vallon-Christersson, Johan et al.

Ingår i PLOS ONE, 2024

• DOI för High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
• Ladda ner fulltext (pdf) av High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

Godina, Christopher; Belting, Mattias; Vallon-Christersson, Johan; Isaksson, Karolin et al.

Ingår i Scientific Reports, 2024

• DOI för Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
• Ladda ner fulltext (pdf) av Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer

Godina, Christopher; Tryggvadottir, Helga; Bosch, Ana; Borgquist, Signe et al.

Ingår i Breast Cancer Research and Treatment, s. 335-347, 2023

• DOI för Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
• Ladda ner fulltext (pdf) av Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer

Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival

Pocas, Juliana; Marques, Catarina; Gomes, Catarina; Otake, Andreia Hanada et al.

Ingår i Proceedings of the National Academy of Sciences of the United States of America, 2023

• DOI för Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival
• Ladda ner fulltext (pdf) av Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival

Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN-A Randomized Trial with Low Molecular Weight Heparin

Bendahl, Par-Ola; Belting, Mattias; Gezelius, Emelie

Ingår i Cancers, 2023

• DOI för Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN-A Randomized Trial with Low Molecular Weight Heparin
• Ladda ner fulltext (pdf) av Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN-A Randomized Trial with Low Molecular Weight Heparin

Endogenous incretin levels and risk of first incident cancer: a prospective cohort study

Jujic, Amra; Godina, Christopher; Belting, Mattias; Melander, Olle et al.

Ingår i Scientific Reports, 2023

• DOI för Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
• Ladda ner fulltext (pdf) av Endogenous incretin levels and risk of first incident cancer: a prospective cohort study

Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma

Ehinger, Erik; Kopecky, Jan; Darabi, Anna; Visse, Edward et al.

Ingår i BMC Neurology, 2023

• DOI för Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma
• Ladda ner fulltext (pdf) av Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma

Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization

Governa, Valeria; Talbot, Hugo; de Oliveira, Kelin Goncalves; Cerezo-Magana, Myriam et al.

Ingår i Proceedings of the National Academy of Sciences of the United States of America, 2022

• DOI för Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization

Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)

Gezelius, Emelie; Bendahl, Paer-Ola; Gallo, Widet; de Oliveira, Kelin Goncalves et al.

Ingår i Cancers, 2022

• DOI för Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
• Ladda ner fulltext (pdf) av Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)

Glioblastoma CD105(+) cells define a SOX2(-) cancer stem cell-like subpopulation in the pre-invasive niche

Li, Jiaxin; Ek, Fredrik; Olsson, Roger; Belting, Mattias et al.

Ingår i Acta neuropathologica communications, 2022

• DOI för Glioblastoma CD105(+) cells define a SOX2(-) cancer stem cell-like subpopulation in the pre-invasive niche
• Ladda ner fulltext (pdf) av Glioblastoma CD105(+) cells define a SOX2(-) cancer stem cell-like subpopulation in the pre-invasive niche

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer

Godina, Christopher; Chandran, Vineesh Indira; Barbachowska, Magdalena; Tryggvadottir, Helga et al.

Ingår i Translational Oncology, 2022

• DOI för Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
• Ladda ner fulltext (pdf) av Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer

The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2

Berg, Tracy J.; Marques, Carolina; Pantazopoulou, Vasiliki; Johansson, Elinn et al.

Ingår i Cancer Research, s. 2101-2115, 2021

• DOI för The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2

Hypoxic Induction of Exosome Uptake through Proteoglycan-Dependent Endocytosis Fuels the Lipid Droplet Phenotype in Glioma

Cerezo-Magana, Myriam; Christianson, Helena C.; van Kuppevelt, Toin H.; Forsberg Nilsson, Karin et al.

Ingår i Molecular Cancer Research, s. 528-540, 2021

• DOI för Hypoxic Induction of Exosome Uptake through Proteoglycan-Dependent Endocytosis Fuels the Lipid Droplet Phenotype in Glioma

The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial

Feldt, Maria; Menard, Julien; Rosendahl, Ann H.; Lettiero, Barbara et al.

Ingår i Cancer & Metabolism, 2020

• DOI för The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial
• Ladda ner fulltext (pdf) av The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial

Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1

Chandran, Vineesh Indira; Mansson, Ann-Sofie; Barbachowska, Magdalena; Cerezo-Magana, Myriam et al.

Ingår i Molecular Cancer Research, s. 644-656, 2020

• DOI för Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1

Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics

Chandran, Vineesh Indira; Welinder, Charlotte; de Oliveira, Kelin Goncalves; Cerezo-Magana, Myriam et al.

Ingår i Journal of Neuro-Oncology, s. 477-488, 2019

• DOI för Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics
• Ladda ner fulltext (pdf) av Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics

Biomarkers of venous thromboembolism in cancer: a silent echo from local events?

Gezelius, Emelie; Belting, Mattias

Ingår i Biomarkers in Medicine, s. 507-509, 2019

• DOI för Biomarkers of venous thromboembolism in cancer: a silent echo from local events?

Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)

Gezelius, E.; Bendahl, P. O.; de Oliveira, K. Goncalves; Ek, L. et al.

Ingår i European Journal of Cancer, s. 82-90, 2019

• DOI för Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
• Ladda ner fulltext (pdf) av Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)

Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma

Chandran, Vineesh Indira; Welinder, Charlotte; Mansson, Ann-Sofie; Offer, Svenja et al.

Ingår i Clinical Cancer Research, s. 3115-3127, 2019

• DOI för Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma

Proteoglycans: a common portal for SARS-CoV-2 and extracellular vesicle uptake

Cerezo-Magana, Myriam; Bång-Rudenstam, Anna; Belting, Mattias

Ingår i American Journal of Physiology - Cell Physiology, 2023

• DOI för Proteoglycans: a common portal for SARS-CoV-2 and extracellular vesicle uptake

Predictive biomarkers in radioresistant rectal cancer: A systematic review

Slipsager, Anna; Henrichsen, Sofie N.; Falkmer, Ursula G.; Dybkaer, Karen et al.

Ingår i Critical reviews in oncology/hematology, 2023

• DOI för Predictive biomarkers in radioresistant rectal cancer: A systematic review
• Ladda ner fulltext (pdf) av Predictive biomarkers in radioresistant rectal cancer: A systematic review

The pleiotropic role of proteoglycans in extracellular vesicle mediated communication in the tumor microenvironment

Cerezo-Magana, M.; Bang-Rudenstam, A.; Belting, Mattias

Ingår i Seminars in Cancer Biology, s. 99-107, 2020

• DOI för The pleiotropic role of proteoglycans in extracellular vesicle mediated communication in the tumor microenvironment
• Ladda ner fulltext (pdf) av The pleiotropic role of proteoglycans in extracellular vesicle mediated communication in the tumor microenvironment